Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ataraxis AI
AddedJun 26, 2026
UpdatedJun 26, 2026
Ataraxis AI

Ataraxis AI

Series A

Ataraxis AI develops AI-powered precision medicine tools for cancer care, integrating digital pathology and clinical data to personalize treatment selection.

HQ
New York, NY, US
Founded
2023
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Ataraxis AI is a precision oncology company building AI-powered clinical tests to personalize cancer care. Its flagship platform, Ataraxis Breast, integrates routine digital pathology with clinical data to generate prognostic and predictive patient-specific insights.

The company was founded by Jan Witowski, MD, PhD, and Krzysztof Geras, PhD, and has developed AI foundation models such as Kestrel and Falcon trained on pan-cancer pathology data. Ataraxis Breast offers a suite of tests including RISK (recurrence prediction), CTX (chemotherapy benefit), and NEO (neoadjuvant therapy response), all delivered through a CLIA-certified laboratory with same-day turnaround.

Ataraxis AI - Products & Services

  • Ataraxis Breast logo

    Ataraxis Breast

    AI-powered clinical tests for breast cancer treatment selection, integrating pathology and clinical data to predict recurrence risk and therapy response.

    Competing Products

    Tempus logo

Ataraxis AI - Similar Companies

Tempus logo

Tempus

tempus.com

Artera logo

Artera

artera.ai

Precision Health AI logo

Precision Health AI

Slideflow Labs logo

Slideflow Labs

slideflow.ai

AIxMed logo

AIxMed

aixmed.com

Paige logo

Paige

paige.ai

Onc.AI logo

Onc.AI

onc.ai

Arctic Fox AI logo

Arctic Fox AI

afxmedical.com

Pathos AI logo

Pathos AI

pathos.com

Arul Health logo

Arul Health

arulhealth.com

PathAI logo

PathAI

Singularity.AI logo

Singularity.AI

singularity.ai

Patronus AI logo

Patronus AI

patronus.ai

BioAI Health logo

BioAI Health

bioaihealth.com

Genomate Health logo

Genomate Health

genomate.health

Ataraxis AI - Quick Facts

Who are Ataraxis AI's competitors?

Companies similar to Ataraxis AI include Tempus, Artera, Precision Health AI and Slideflow Labs.

When was Ataraxis AI founded?

Ataraxis AI was founded in 2023.

Where is Ataraxis AI's headquarters located?

Ataraxis AI's headquarters is located in New York, NY, US.

When was Ataraxis AI's last funding round?

Ataraxis AI's most recent funding round was for $20.4M (USD) in March 2025.

How much has Ataraxis AI raised to-date?

As of Mar 5, 2025, Ataraxis AI has raised a total of $20.4M (USD).

Ataraxis AI - Classification

Industry
  • AI
  • Healthcare Technology
Ownership
  • Private
Technology
  • AI
  • AI Machine Learning
Model
  • Biotechnology Company
Revenue
  • B2B
Customer
  • Healthcare Providers
Tags
  • Precision Oncology